Idera Pharmaceuticals Inc(IDRA)
1.02
Change: 0 (0)
As of Wed 10/06/2021 03:01 AM% Of Value
Growth
Value Per Share
:
:
:
-12.07
-100.00
-8.4500 (as of 19/07/2019)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
| Open | 2.59 | Dividend | 128 |
| Close Price | 1.02 | DivYield | 0 % |
| High | 2.75 | Growth | 0.0 |
| Low | 2.5 | Growth% | -100.00 |
| P/e | -1.208 | Volume | 146,641.0 |
| P/b | -0.41 | Market Capital | 43.1 M |
| Highest High | 2.67 | Lowest Low | 1.33 |
| 50 Days Moving Average | 2.71 (as of 19/07/2019) | 50 Days Moving Average Percentage | 1.01 (as of 19/07/2019 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 902,000.0 | 662,000.0 | 1.4 M | 0.0 | 0.0 |
| Cap Spending | -206,000.0 | 215,000.0 | 0.0 | -8,000.0 | 0.0 |
| Operating Expenses | 67.3 M | 61.6 M | 47.5 M | 36.6 M | 27.6 M |
| Operating Cash Flow | -66.4 M | -60.9 M | -46.0 M | -36.6 M | -27.6 M |
| Free Cash Flow | -55.4 M | -51.7 M | -44.4 M | -33.7 M | -24.5 M |
| Free Cash Flow Per Share | -2.819 | -1.944 | -1.559 | -0.999 | -0.5 |
| Total liabilities | 209,000.0 | 0.0 | 1.0 M | 949,000.0 | 758,000.0 |
| Total cash | 112.6 M | 71.4 M | 40.0 M | 33.2 M | 32.5 M |
| ROE% | -0.788 | -0.742 | -2.604 | 3.186 | 2.721 |
| Outstanding Shares | 24.4 M | 27.6 M | 30.5 M | 42.2 M | 52.9 M |
| P/E | -5.959 | -1.208 | -0.383 | -1.845 | 0.273 |
| P/S | 435.95 | 109.312 | 22.356 | ||
| Revenue USD | 902,000.0 | 662,000.0 | 1.4 M | 0.0 | 0.0 |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|